Teleflex Incorporated (TFX) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
TFX Revenue Growth
Revenue Breakdown (FY 2025)
TFX's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
TFX Revenue Analysis (2014–2025)
As of May 8, 2026, Teleflex Incorporated (TFX) generated trailing twelve-month (TTM) revenue of $2.81 billion, reflecting significant decline in growth of -21.8% year-over-year. The most recent quarter (Q1 2026) recorded $548.3 million in revenue, down 3.6% sequentially.
Looking at the longer-term picture, TFX's 5-year compound annual growth rate (CAGR) stands at -4.7%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $3.05 billion in 2024.
Revenue diversification analysis shows TFX's business is primarily driven by Vascular Access (46%), Interventional (33%), and Surgical (21%).
When compared to Healthcare sector peers including ICU (+1195.6% YoY), UTMD (-5.8% YoY), and ATRC (+15.0% YoY), TFX has underperformed the peer group in terms of revenue growth. Compare TFX vs ICU →
TFX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TFXCurrent | $2.8B | -21.8% | -4.7% | 12.8% | |
 ICU | $135,000 | +1195.6% | - | -13216.3% | |
 UTMD | $39M | -5.8% | -1.8% | 29.6% | |
 ATRC | $535M | +15.0% | +20.9% | -0.6% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 ANGO | $292M | +7.3% | +2.1% | -13.7% |
TFX Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.99B | -34.6% | $1.12B | 56.2% | $255.8M | 12.8% |
| 2024 | $3.05B | +2.4% | $1.70B | 55.9% | $151.0M | 5.0% |
| 2023 | $2.97B | +6.6% | $1.65B | 55.4% | $506.3M | 17.0% |
| 2022 | $2.79B | -0.7% | $1.53B | 54.9% | $499.7M | 17.9% |
| 2021 | $2.81B | +10.7% | $1.55B | 55.2% | $628.1M | 22.4% |
| 2020 | $2.54B | -2.2% | $1.32B | 52.2% | $423.1M | 16.7% |
| 2019 | $2.60B | +6.0% | $1.41B | 54.3% | $427.3M | 16.5% |
| 2018 | $2.45B | +14.1% | $1.38B | 56.5% | $321.7M | 13.1% |
| 2017 | $2.15B | +14.9% | $1.17B | 54.6% | $372.3M | 17.3% |
| 2016 | $1.87B | +3.2% | $996.2M | 53.3% | $319.5M | 17.1% |
See TFX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TFX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TFX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTFX — Frequently Asked Questions
Quick answers to the most common questions about buying TFX stock.
Is TFX's revenue growth accelerating or slowing?
TFX revenue declined -21.8% year-over-year, contrasting with the 5-year CAGR of -4.7%. TTM revenue fell to $2.8B. This reverses the prior growth trend.
What is TFX's long-term revenue growth rate?
Teleflex Incorporated's 5-year revenue CAGR of -4.7% reflects the variable expansion pattern. Current YoY growth of -21.8% is below this long-term average.
How is TFX's revenue distributed by segment?
TFX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.